ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
35 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

ZIOPHARM Oncology, Inc. (ZIOPHARM), formerly EasyWeb, Inc. is a biotechnology company that discovers and develops cancer therapies. The company develops novel gene expression, control and cell technologies to deliver safe, effective and scalable cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD). It offers engineering techniques and multi-genic gene programs to develop next-generation patient- and donor-derived adoptive cellular therapies. ZIOPHARMs pipeline products include Ad-RTS-IL-12 and CAR/Cytokine Products.

ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale,

  
Source:
Document ID
GDPH24573D
Country
Industry
Ticker
ZIOP=US
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
ZIOPHARM Oncology, Inc., Pharmaceuticals &Healthcare, Deal Details1022
  Partnerships101
    Intrexon Enters into Co-Development Agreement with Ziopharm Oncology101
    Ziopharm Expands Co-Development Agreement with Intrexon111
    Mesoblast Enters Into Co-Development Agreement With Intrexon And Ziopharm Oncology122
    Ziopharm Oncology Plans To Enter Into Co-Marketing Agreement For Palifosfamide141
    ZIOPHARM Oncology Enters Into Co-Development Agreement With Intrexon152
  Licensing Agreements171
    Intrexon, Ziopharm Oncology Enter into Licensing Agreement with University of Texas MD Anderson Cancer Center172
    Ziopharm Amends Licensing Agreement with Solasia Pharma for Darinaparsin192
    ZIOPHARM Oncology Enters Into Licensing Agreement With Solasia Pharma For Darinaparsin212
  Equity Offering231
    Ziopharm Oncology Completes Exercise of Over-Allotment Option of Public Offering of Shares for USD100.6 Million232
    Ziopharm Oncology Completes Public Offering Of Shares For US$50 Million251
    ZIOPHARM Oncology Completes Public Offering Of Common Stock For US$50 Million262
    ZIOPHARM Oncology Completes An Underwritten Public Offering Of US$63.5 Million282
    ZIOPHARM Oncology Completes Underwritten Public Offering For US$35 Million302
ZIOPHARM Oncology, Inc. - Key Competitors321
Key Employees331
Locations And Subsidiaries341
  Head Office341
Appendix351
  Methodology351
  About GlobalData351
  Contact Us351
  Disclaimer351

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ZIOPHARM-Oncology-Inc-ZIOP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7853>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). ZIOPHARM Oncology, Inc. (ZIOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/ZIOPHARM-Oncology-Inc-ZIOP-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7853>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research